The competitive rower-turned-researcher spoke to Spectrum about how trying out for the U.S. national rowing team and a subsequent coaching position shaped her study of speech development.
Spectrum: Autism Research News
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
One drug blocks mTOR signaling, and the other stops the blocker from acting anywhere in the body but the brain, lowering the potential for side effects.
Parents’ health, treatment dosages and sensory perception feature in this month’s crop of null and replicated results.
Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.
The drug quells seizures in children with Dravet syndrome or Lennox-Gastaut syndrome.
The field of ABA needs more compassion and individualization.
Prenatal exposure to topiramate increases a child’s autism odds, according to the study that prompted the inquiry, but experts caution that pregnant people with epilepsy have few other options for controlling seizures.
Roche’s gene therapy drug Rugonersen boosts expression of the protein missing in the syndrome in mice and monkeys, but whether it works in people remains to be seen.